ABN202 (anti Trop2-interferon beta mutein)

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameABN202 (anti Trop2-interferon beta mutein)
Drug Alias NameABN202 (anti Trop2-interferon beta mutein)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionApoptosis stimulantsAnti-Trop-2Interferon beta inhibitors
TargetsTumor-associated calcium signal transducer 2Interferon beta
Therapy Area/IndicationsLung NeoplasmsPancreatic NeoplasmsStomach Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbion Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbion Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsPancreatic NeoplasmsStomach Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A